-
Energy crisis fuels calls to cut methane emissions
-
Europe, Canada pull together in Yerevan in Trump's shadow
-
India's Modi eyes important win in opposition-held West Bengal
-
Hantavirus: spread by rodents, potentially fatal, with no specific cure
-
French starlet Seixas to ride Tour de France in July
-
Cruise ship operator says Dutch to repatriate two ill passengers
-
India's Modi eyes win in opposition-held West Bengal
-
In Wales, UK Labour Party loses grip on storied heartland
-
Musk vs OpenAI trial enters second week
-
India's Modi faces key test as vote count underway
-
Japan PM says oil crisis has 'enormous impact' in Asia-Pacific
-
Badminton no.1 An brings 'fire' as South Korea win Uber Cup
-
Saka sparks Arsenal attack into life ahead of Atletico showdown
-
Atletico aim to show Alvarez their ambition in Arsenal semi
-
Seoul, Taipei hit records as Asian stocks track Wall St tech rally
-
Boeing faces civil trial over 737 MAX crash
-
Australian inquiry opens public hearings into Bondi Beach shooting
-
Iran warns of ceasefire violation as US plans to escort Hormuz ships
-
North Korean club to play rare football match in South
-
Pistons rout Magic to cap comeback, book NBA playoff clash with Cavaliers
-
Japan, Australia discuss energy, critical minerals
-
Village braces for closure of Spain's largest nuclear plant
-
GameStop makes $56 billion takeover bid for eBay
-
Ex-NY mayor Giuliani hospitalized in 'critical' condition: spokesman
-
Europe, Canada leaders hold Yerevan talks in Trump's shadow
-
'No pilgrims': regional war hushes Iraq's holy cities
-
Israel court extends detention of two Gaza flotilla activists
-
Massive search continues for two missing US soldiers in Morocco
-
Players keep up battle with tennis majors as they decry Roland Garros prize money
-
Pacific Avenue Capital Partners Enters into Exclusive Negotiations to Acquire ESE World, Amcor's European Waste Container Business
-
Securitas Acquires CamVision to Expand Packaged and Advanced Security Solutions in Denmark
-
Pistons rout Magic to complete comeback, advance in NBA playoffs
-
Trump says US and Iran in 'positive' talks, unveils plan to escort Hormuz ships
-
Talisman Endrick fires resurgent Lyon into third in France
-
Verstappen laments spin and struggle for pace in Miami
-
Teen Antonelli wins again in Miami to extend title race lead
-
Ferrari's Leclerc admits he threw away Miami podium finish
-
Cristian Chivu, a winner with Inter on the pitch and in the dugout
-
Key players from Inter Milan's Serie A title triumph
-
No.4 Young cruises to PGA title at Doral
-
Vinicius double delays Barca title as Real Madrid down Espanyol
-
Inter Milan win Italian title for third time in six seasons
-
Spurs solved mental frailty to boost survival bid: De Zerbi
-
Miami champ Antonelli shrugs off success, vows 'back to work'
-
Man Utd beat Liverpool, Spurs climb out of relegation zone
-
Spurs out of relegation zone after vital win at Villa
-
No.1 Korda cruises to LPGA Mexico crown
-
Thompson-Herah shines at world relays, Tebogo helps Botswana to win
-
Three die on Atlantic cruise ship from suspected hantavirus: WHO
-
Germany's Merz says not 'giving up on working with Donald Trump'
Disgraced surgeon on trial in Sweden over windpipe transplants
An Italian doctor who made headlines for pioneering windpipe surgery went on trial in Sweden on Wednesday, charged with assault for performing the experimental procedure.
Paolo Macchiarini won praise in 2011 after claiming to have performed the world's first synthetic trachea transplants using stem cells while he was a surgeon at Stockholm's Karolinska Institute.
The procedure was hailed as a breakthrough in regenerative medicine.
But allegations soon emerged that the risky procedure had been carried out on at least one person who had not been critically ill at the time of the operation.
The 63-year-old appeared in court in a blue suit Wednesday, where he listened to translated audio as prosecutors listed the charges of "aggravated assault" against three patients.
- 'Disregard for science' -
The Karolinska Institute has confirmed that the three individuals have since died, but did not directly link the deaths to the operations.
"Macchiarini has carried out the surgery with complete disregard for science and tried experience," prosecutor Karin Lundstrom-Kron told the court.
As prosecutors presented their case they referenced both external and internal reviews of the case, including one published in 2016 by physician Kjell Asplund, who argued that Macchiarini should never have been employed by Karolinska in the first place.
"It is clear that this method has not worked," prosecutor Jim Westerberg said, adding that Macchiarini had embellished the benefits of the procedure.
Macchiarini, who took notes without showing much emotion, has maintained the operations constituted treatments and not experiments, and denied being criminally responsible.
"He contends that he has performed health care, cured and helped," Macchiarini's lawyer Bjorn Hurtig told AFP during a recess.
The prosecution's presentation of evidence is expected to continue over several days so the defence will likely not be able to present its side until next week.
But Hurtig said they had "high hopes" they would be able to counter the prosecution's evidence.
"There are quite a lot of gaps in that evidence and there is a lot of evidence that we argue are favourable to our view of things," he said.
- Downplayed risks -
In 2013, the Karolinska hospital suspended all transplants and refused to extend Macchiarini's contract as a surgeon.
A year later, several surgeons at the hospital filed a complaint alleging that Macchiarini had downplayed the risks of the procedure.
Macchiarini carried out three surgeries at Karolinska University Hospital in 2011 and 2012, using an artificial windpipe made of plastic and coating it with the patient's own stem cells.
Together with his colleagues, he performed a total of eight such transplants between 2011 and 2014, the five others taking place in Russia.
An external review in 2015 found Macchiarini guilty of research misconduct, but despite sacking him, the Karolinska Institute repeatedly defended him until 2018, when it found him and several other researchers guilty.
The university's principal stepped down over the scandal, as well as a number of other people.
Medical journal The Lancet in 2018 retracted two papers authored by Macchiarini.
The trial, held in the Solna district court near the Karolinska Institute, is scheduled to take place over 13 days.
C.Meier--BTB